Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Potentially new therapeutic target for joint rheumatism has been identified

The scientists working with the lead author Berno Dankbar of the Institute for Experimental Muscle and Skeletal Medicine at the Medical University of Münster in Germany and the University Clinic for Internal Medicine III at Vienna’s General Hospital/Rheumatology of the Medical University of Vienna are concentrating on the growth and differentiation factor 8, also known as myostatin. It is produced mainly in muscle tissue.

"If one removes the myostatin gene from mice, this leads to muscle hypertrophy (Note: overly strong muscle growth). Studies on animal models support the premise that myostatin is a negative regulator for muscle growth and regeneration. A lack of myostatin promotes bone growth“, say the scientists, including Silvia Hayer and Kurt Redlich from the Vienna University Hospital.

"The results strongly suggest that myostatin could be an important goal in order to impact the formation of osteoclasts and damage to joints in the case of rheumatoid arthritis“, the authors wrote. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Expand to Austria

    26.06.2019, Brescia, Italy

  • Research Dialogue with Summery Jazz Sounds

    02.07.2019, Stuttgart, Germany

Austria Map

Find the perfect location for your company

Thanks to a fantastic mindset, our employees at the Villach site have built up a unique expertise which helps us to further strengthen our position on the global market. We fuse high-performance manufacturing with research and development in the field of power electronics. In addition to a very good cooperation with partners and networks, a well-developed landscape of 'talent factories' ranging from higher technical colleges to universities, we as a company also value the outstanding model of research promotion which exists in Austria.

Infineon

Logo Infineon
More testimonials

news from the business location Austria

Ottobock invests EUR 2 million in Vienna

The underlying basis of success of the globally recognised development work of the German life sciences company Ottobock being carried out in Vienna is the extremely pronounced medical research landscape offering fertile ground for interdisciplinary R&D projects.

Innovations from Austria for the Logistics Sector

At the present time there are many influencing factors which pose challenges to the supply chain and logistics management. Solutions in this area are frequently developed by startups, also from Austria. Several of them will present their innovations at the Austrian Logistics Day and Logistics Future Lab.

More news All blog posts